Cargando…
Oncolytic viral immunotherapy in the time of COVID-19
Autores principales: | Olagnier, David, Alain, Tommy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610094/ https://www.ncbi.nlm.nih.gov/pubmed/33183956 http://dx.doi.org/10.1016/j.cytogfr.2020.10.009 |
Ejemplares similares
-
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
por: Russell, Luke, et al.
Publicado: (2019) -
Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
por: Robilotti, Elizabeth, et al.
Publicado: (2023) -
Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021) -
Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020) -
Oncolytic Adenovirus in Cancer Immunotherapy
por: Peter, Malin, et al.
Publicado: (2020)